In today’s biotech landscape, what’s strategic is not only scientific. It is also tied to macroeconomic and geopolitical trends. And that’s exactly what we’ll explore on Wednesday, June 11, at the event “Global Strategies for Biotechnology”, held at the Fundación Parque Tecnológico de la Salud in Granada.
Over the course of one morning, in four focused sessions led by Mónica Rosoff, founder of LBBAL Alianza and expert in global biopharma alliances, we’ll dive into the issues shaping success in 2025:
💰 Funding – What does global funding look like for biotech companies, and what approaches should European innovators consider?
🌏 Commercial Considerations – How are emerging policies, such as those relating to tariffs and pricing impact biotechs? These are impacts beyond Big Pharma. It affects every company with international ambition.
🧭 Strategy from Day One – Starting a biotech requires great science, but there is much more to consider. We’ll talk about how to embed strategic resilience and scale-readiness from the beginning.
🤝🏻 International collaboration – Innovation knows no borders. What new partnering opportunities are emerging between the U.S., Europe, and Asia—and how do we navigate them?
But more than topics, this is a space for real dialogue. For sharing lessons that don’t make it into slides, and for connecting—human to human—with those building the future of biotech.
📍 Fundación Parque Tecnológico de la Salud, Granada
🗓️ Wednesday, June 11 | 09:00 – 13:30
🎟️ Free registration required – Space is limited.
👉🏻 Register by scanning the QR code on the invitation.
We’d love to see you there. Because building global biotech starts with showing up—locally, thoughtfully, together.
